Martina Damo

University of Chicago — United States

Immunology and Microbiology · Life Sciences

14h-index1.9kcitations36works20.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(20), Immune Cell Function and Interaction(19), T-cell and B-cell Immunology(13), Cancer Immunotherapy and Biomarkers(13), RNA Interference and Gene Delivery(7)

Publications36 total

CD8 T cells mediate immunosurveillance for neoantigen+ epithelial stem cells in the colon
2025
KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection
Science·2025· 43 citedOpen Access
Intestinal tuft cell immune privilege enables norovirus persistence
Science Immunology·2024· 17 citedOpen Access
PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens
Nature·2023· 70 citedOpen Access
Tuft cell tropism enables norovirus evasion of CD8+ T cells and viral persistence
The Journal of Immunology·2023Open Access
Mapping the gene space at single-cell resolution with gene signal pattern analysis
The Journal of Immunology·2023Open Access
948 Developing engineered animal models to investigate tumor-specific T cell responses and immune-related adverse events after immunotherapy
Regular and Young Investigator Award Abstracts·2022Open Access
Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection
The Journal of Experimental Medicine·2022· 75 citedOpen Access
Novel Mouse Models for Cancer Immunology
Annual Review of Cancer Biology·2022· 27 citedOpen Access
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
Cell·2021· 450 citedOpen Access
A reservoir of stem-like CD8 <sup>+</sup> T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response
Science Immunology·2021· 326 citedOpen Access
LB778 A quantitative scoring system for cutaneous immune-related adverse events
Journal of Investigative Dermatology·2021
The PD-1 checkpoint receptor maintains tolerance of self-reactive CD8 T cell in skin
2021· 1 citedOpen Access
Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8+ T Cell Tolerance Development
Frontiers in Immunology·2021· 13 citedOpen Access
A reservoir of stem-like CD8 T cells in the tumor-draining lymph node maintains the ongoing anti-tumor immune response
2021· 8 citedOpen Access
The PD-1 Checkpoint Receptor Maintains Tolerance of Self-Reactive CD8 T Cell in Skin
SSRN Electronic Journal·2021Open Access
Neoantigen driven B cell and CD4 <sup>+</sup> T follicular helper cell collaboration promotes robust anti-tumor CD8 <sup>+</sup> T cell responses
2020· 2 citedOpen Access
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk
UNC Libraries·2020Open Access
Inducible de novo expression of neoantigens in tumor cells and mice
Nature Biotechnology·2020· 54 citedOpen Access
Abstract PR5: Investigating the mechanisms of immune-related adverse events using engineered animal models
Cancer Immunology Research·2020
page 1 of 2Next →

Frequent Co-authors

Nikhil S. Joshi(23), Can Cui(11), Kelli A. Connolly(11), Eric Fagerberg(9), Brittany Fitzgerald(8), Ivana William(8), Noah I. Hornick(7), Jeffrey A. Hubbell(7), Gena G. Foster(6), Smita Krishnaswamy(6), David S. Wilson(6), Jiawei Wang(5), Julie F. Cheung(5), Aarthi Venkat(5), Isabel Monroy(5), Weiguo Cui(5), Alessio Cantore(4), Luigi Naldini(4), Achia Khatun(4), Moujtaba Y. Kasmani(4)